Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection.
about
Mouse models in liver cancer research: A review of current literatureImmune therapy for hepatitis BHepatitis B Virus Immunopathology, Model Systems, and Current TherapiesImmune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.Establishment and primary application of a mouse model with hepatitis B virus replication.Generation of the regulatory protein rtTA transgenic mice.IL-33 Enhances Humoral Immunity Against Chronic HBV Infection Through Activating CD4(+)CXCR5(+) TFH Cells.Investigation on effects of the nourishing kidney and eliminating toxicity decoction on immunological imbalance of Th1, Th17 and Treg in HBV transgenic miceDysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection.Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis.Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling.Mouse models for therapeutic vaccination against hepatitis B virus.Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.Enrichment of Ly6C(hi) monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model.Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata.Entecavir up-regulates dendritic cell function in patients with chronic hepatitis B.Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice.Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells.Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier.
P2860
Q27490350-0D93F943-CEC4-4F80-A473-137EAE79815FQ28078856-A64201CD-9711-4234-9AC3-63BFB146772EQ33559657-4AF83C3A-8461-415A-BAD5-D92E91DDCF7CQ33867720-B898DB1B-DA39-4C82-ABC2-4D26E4E2406CQ34225729-AA4A415E-8042-4314-B403-C922BDD31E9DQ35010274-2AFECE49-14A4-4310-B596-044356B395D2Q35814940-021991FF-ABE6-488C-B892-06B54FF7C0AFQ35870573-E27DAFDE-17D7-474D-B273-E5EF5F6E2C16Q36397230-997DD863-3240-49B6-BB0C-C08D8E24AC2BQ36545096-0D8ADDF4-44E6-4444-8F0B-50267C45BB51Q36784990-1C31D37C-71DE-4A1F-80B9-ABACAC6EF12CQ38293590-04DC22A7-7227-45C2-9BBF-8F86CD5CC101Q39601760-1084000B-A7E4-419D-9AC3-E5E0182F5BC1Q40126197-ECDB02C8-291C-41A5-A181-4C2320508AE9Q42726101-6837A28D-1B8F-4F31-90F8-1F7AF35D4656Q43115094-016D96C2-4516-45D5-AA71-C6DA398C334AQ43159839-C7964C6C-F26D-4F3D-A369-CEA3BF6F8AFEQ43454372-900507AE-023F-453C-93E8-CB63EEB7D279Q43674617-355071B7-59B4-4523-9045-5E6B570E0FFAQ45747501-BABBD1C7-38B8-4F65-A428-C38FF05888D6
P2860
Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@ast
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@en
Hepatitis B virus
@nl
type
label
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@ast
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@en
Hepatitis B virus
@nl
prefLabel
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@ast
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@en
Hepatitis B virus
@nl
P1476
Hepatitis B virus (HBV)-transg ...... athology during HBV infection.
@en
P304
P356
10.1046/J.1365-2613.1998.740406.X
P577
1998-10-01T00:00:00Z